Mingjia Li

896 total citations
30 papers, 326 citations indexed

About

Mingjia Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mingjia Li has authored 30 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Mingjia Li's work include Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Mingjia Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Mingjia Li collaborates with scholars based in United States, Australia and China. Mingjia Li's co-authors include Carolyn J. Presley, Kari Kendra, Gregory A. Otterson, Dwight H. Owen, R. V. Short, Marium Husain, Daniel Spakowicz, David P. Carbone, Jarred Burkart and Madison Grogan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Oncologist.

In The Last Decade

Mingjia Li

26 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjia Li United States 10 217 102 61 53 38 30 326
Marium Husain United States 8 224 1.0× 83 0.8× 46 0.8× 40 0.8× 35 0.9× 34 300
Dinesh de Alwis United States 9 276 1.3× 69 0.7× 44 0.7× 109 2.1× 19 0.5× 19 368
Luis Miguel Juárez‐Salcedo Spain 7 102 0.5× 59 0.6× 86 1.4× 75 1.4× 28 0.7× 24 325
Alberto Arcediano Spain 9 229 1.1× 101 1.0× 50 0.8× 19 0.4× 23 0.6× 15 341
Aurore Vozy France 4 345 1.6× 117 1.1× 37 0.6× 69 1.3× 29 0.8× 17 423
Matthew Brown United Kingdom 9 109 0.5× 74 0.7× 55 0.9× 63 1.2× 26 0.7× 18 294
Doran Ksienski Canada 9 270 1.2× 130 1.3× 34 0.6× 48 0.9× 38 1.0× 20 353
Vishal Navani Canada 11 205 0.9× 172 1.7× 87 1.4× 42 0.8× 34 0.9× 38 338
Mitchell S. von Itzstein United States 11 222 1.0× 101 1.0× 42 0.7× 60 1.1× 40 1.1× 32 344
Robert Chapman United Kingdom 9 88 0.4× 85 0.8× 101 1.7× 95 1.8× 46 1.2× 28 331

Countries citing papers authored by Mingjia Li

Since Specialization
Citations

This map shows the geographic impact of Mingjia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjia Li more than expected).

Fields of papers citing papers by Mingjia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjia Li. The network helps show where Mingjia Li may publish in the future.

Co-authorship network of co-authors of Mingjia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjia Li. A scholar is included among the top collaborators of Mingjia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjia Li. Mingjia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johns, Natalie, Songzhu Zhao, Po‐Lan Su, et al.. (2025). CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches. Journal of the National Comprehensive Cancer Network. 23(3.5). 1 indexed citations
2.
Hong, Feng, Yuanquan Yang, Eric A. Singer, et al.. (2025). Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches. Cancer Drug Resistance. 8. 9–9. 5 indexed citations
3.
Kwon, Hyunwoo, Mingjia Li, Anjun Ma, et al.. (2024). Eosinophil-neutrophil ratio as a sex-dependent prognostic marker in immune checkpoint therapy for metastatic NSCLC and transcriptomic evaluation of intratumoral eosinophil-T cell interaction.. Journal of Clinical Oncology. 42(16_suppl). 8586–8586. 1 indexed citations
4.
Kwon, Hyunwoo, Mingjia Li, Nicholas Jones, et al.. (2024). Case report: Hypereosinophilia in non-small cell lung cancer. SHILAP Revista de lepidopterología. 13. 100275–100275.
5.
6.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2023). Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer. The Oncologist. 28(8). e625–e632. 7 indexed citations
7.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2023). Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy. Cancer Immunology Immunotherapy. 72(7). 2005–2013. 7 indexed citations
8.
Wong, Alex H.C., Songzhu Zhao, Mingjia Li, et al.. (2023). Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis. Cancer Immunology Immunotherapy. 72(6). 1727–1735. 8 indexed citations
9.
Tinoco, Gabriel, Songzhu Zhao, Lai Wei, et al.. (2022). Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival. Journal of Cancer Research and Clinical Oncology. 149(5). 2235–2242. 25 indexed citations
10.
Chen, Victor, et al.. (2022). Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report. Journal of Medical Case Reports. 16(1). 177–177.
11.
Yang, Yuanquan, et al.. (2022). Salvage nivolumab and ipilimumab after prior anti‐PD‐1/PD‐L1 therapy in metastatic renal cell carcinoma: A meta‐analysis. Cancer Medicine. 11(7). 1669–1677. 8 indexed citations
12.
Zhao, Songzhu, Mingjia Li, Sandip H. Patel, et al.. (2021). Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival. Cancer Immunology Immunotherapy. 71(5). 1157–1165. 24 indexed citations
13.
Zhang, Shijun, Chien‐Wei Chiang, Gregory A. Otterson, et al.. (2021). Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events. Cancer Immunology Immunotherapy. 70(10). 2761–2769. 10 indexed citations
14.
Li, Mingjia, Natalie Spaccarelli, Kari Kendra, Richard C. Wu, & Claire F. Verschraegen. (2021). Refractory dermatitis contributed by pityriasis versicolor: a case report. Journal of Medical Case Reports. 15(1). 212–212. 3 indexed citations
15.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2021). Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer. Journal of Geriatric Oncology. 12(5). 813–819. 27 indexed citations
16.
Husain, Marium, Menglin Xu, Sandipkumar Patel, et al.. (2021). Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.. Journal of Clinical Oncology. 39(15_suppl). 2633–2633. 9 indexed citations
17.
Li, Mingjia, Daniel Spakowicz, Songzhu Zhao, et al.. (2020). Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer. Cancer Immunology Immunotherapy. 69(11). 2403–2408. 12 indexed citations
18.
Li, Mingjia, et al.. (2020). Analysis of SARS-CoV-2 sequences reveals transmission path and emergence of SD 614G mutation. 1995–1998. 1 indexed citations
19.
Li, Mingjia, Daniel Spakowicz, Jarred Burkart, et al.. (2019). Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers. Journal of Cancer Research and Clinical Oncology. 145(10). 2541–2546. 82 indexed citations
20.
Li, Mingjia & R. V. Short. (2002). How Oestrogen or Progesterone might Change a woman's susceptibility to HIV‐1 infection. Australian and New Zealand Journal of Obstetrics and Gynaecology. 42(5). 472–475. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marium Husain Breakdown of academic impact, for papers by Dinesh de Alwis Breakdown of academic impact, for papers by Luis Miguel Juárez‐Salcedo Breakdown of academic impact, for papers by Alberto Arcediano Breakdown of academic impact, for papers by Aurore Vozy Breakdown of academic impact, for papers by Matthew Brown Breakdown of academic impact, for papers by Doran Ksienski Breakdown of academic impact, for papers by Vishal Navani Breakdown of academic impact, for papers by Mitchell S. von Itzstein Breakdown of academic impact, for papers by Robert Chapman
Rankless by CCL
2026